We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+13.17%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$33.6B
AUM Growth
+$1.34B
(+4.1%)
Cap. Flow
-$1.43B
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
13.71%
Holding
2,962
New
772
Increased
492
Reduced
601
Closed
858
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$431M |
| 2 |
NVIDIA
NVDA
|
+$220M |
| 3 |
Micron Technology
MU
|
+$182M |
| 4 |
Union Pacific
UNP
|
+$168M |
| 5 |
Southern Company
SO
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$459M |
| 2 |
Meta Platforms (Facebook)
META
|
+$403M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$380M |
| 4 |
Salesforce
CRM
|
+$271M |
| 5 |
Intel
INTC
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.23% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 9.64% |
| 5 | Energy | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
1701
DELISTED
Faro Technologies
FARO
| $25.9K | ﹤0.01% |
+1,596
| New | +$28.2K |
|
1702
Community Trust Bancorp
CTBI
$1.44B
| $25.7K | ﹤0.01% |
+722
| New | +$26K |
|
1703
AbCellera Biologics
ABCL
$1.86B
| $25.6K | ﹤0.01% |
+3,959
| New | +$27K |
|
1704
Editas Medicine
EDIT
$425M
| $25.3K | ﹤0.01% |
3,079
-224,721
| -99% | -$1.96M |
|
1705
Chegg
CHGG
$115M
| $25.2K | ﹤0.01% |
+2,835
| New | +$34.4K |
|
1706
Diodes
DIOD
$4.06B
| $25K | ﹤0.01% |
270
-1,756
| -87% | -$155K |
|
1707
Aemetis
AMTX
$114M
| $24.9K | ﹤0.01% |
+3,401
| New | +$12.9K |
|
|
LTCH
1708
DELISTED
Latch, Inc. Common Stock
LTCH
| $24.8K | ﹤0.01% |
+17,822
| New | +$16.7K |
|
1709
DNOW Inc
DNOW
$2.63B
| $24.4K | ﹤0.01% |
2,358
-1,585
| -40% | -$15.9K |
|
1710
Bionano Genomics
BNGO
$12.9M
| $24.3K | ﹤0.01% |
+66
| New | +$29.8K |
|
1711
Heritage Financial
HFWA
$1.25B
| $24K | ﹤0.01% |
+1,485
| New | +$25.8K |
|
1712
Graham Holdings Company
GHC
$5.13B
| $24K | ﹤0.01% |
+42
| New | +$24.3K |
|
1713
Blackbaud
BLKB
$2.07B
| $24K | ﹤0.01% |
337
-6,895
| -95% | -$484K |
|
1714
iRadimed
IRMD
$1.19B
| $23.9K | ﹤0.01% |
+502
| New | +$22.6K |
|
1715
Dave & Buster's
PLAY
$369M
| $23.8K | ﹤0.01% |
533
-103,107
| -99% | -$3.77M |
|
1716
Novavax
NVAX
$1.26B
| $23.7K | ﹤0.01% |
+3,194
| New | +$25.1K |
|
1717
AstraZeneca
AZN
$241B
| $23.5K | ﹤0.01% |
+165
| New | +$24.3K |
|
1718
Telos
TLS
$365M
| $23.5K | ﹤0.01% |
9,194
-20,014
| -69% | -$47.5K |
|
1719
Liquidity Services
LQDT
$1.19B
| $23K | ﹤0.01% |
+1,395
| New | +$20.5K |
|
1720
HUB Group
HUBG
$2.92B
| $22.9K | ﹤0.01% |
570
-69,140
| -99% | -$2.67M |
|
1721
DXP Enterprises
DXPE
$2.65B
| $22.8K | ﹤0.01% |
+627
| New | +$18.9K |
|
1722
Trustmark
TRMK
$2.82B
| $22.8K | ﹤0.01% |
+1,080
| New | +$24.4K |
|
1723
Alto Ingredients
ALTO
$410M
| $22.8K | ﹤0.01% |
+7,876
| New | +$15K |
|
|
LPRO
1724
DELISTED
Open Lending Corp
LPRO
| $22.5K | ﹤0.01% |
+2,140
| New | +$18.9K |
|
1725
Metallus
MTUS
$897M
| $22K | ﹤0.01% |
+1,018
| New | +$18.4K |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Point72 Asset Management held 2,962 positions worth $33.6B, up 4.1% from $32.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Point72 Asset Management withdrew a net $1.43B in Q2 2023, closing 858 positions and reducing 601 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Point72 Asset Management opened a new position in Micron Technology worth $178M.
- Point72 Asset Management's largest Q2 2023 buy was Micron Technology: 2,825,000 shares worth $178M.
- Point72 Asset Management added most to Microsoft in Q2 2023, an estimated $431M increase.
- Point72 Asset Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $459M.
- Point72 Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $157M.
- Point72 Asset Management's ten largest holdings make up 14% of its $33.6B portfolio in Q2 2023.
- Point72 Asset Management opened 772 new positions and closed 858 in Q2 2023.
- Point72 Asset Management's portfolio value rose 4.1% quarter-over-quarter to $33.6B.
Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.